Prognostic value of pretreatment tumor-to-blood standardized uptake ratio (SUR) in rectal cancer.
Fluorodeoxyglucose F18
Positron-emission tomography
Prognosis
Rectal cancer
SUR
Survival
Journal
Annals of nuclear medicine
ISSN: 1864-6433
Titre abrégé: Ann Nucl Med
Pays: Japan
ID NLM: 8913398
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
17
01
2020
accepted:
02
04
2020
pubmed:
17
4
2020
medline:
12
1
2021
entrez:
17
4
2020
Statut:
ppublish
Résumé
The prognostic value of SUV on pretreatment F-18 FDG PET/CT imaging in patients with rectal cancer is a matter of debate. SUR is of prognostic value for survival in different cancers. In this study, we aimed to examine the potential prognostic value of SUR and other parameters in pretreatment F-18 FDG PET/CT for non-metastatic rectal cancer. One hundred four non-metastatic rectal cancer patients who underwent pretreatment PET/CT between March 2012 and January 2018 were included in the study. Firstly, SUV Multivariate Cox regression analysis revealed that SUR was a prognostic factor for PFS. Age and T stage were prognostic factors for both OS and PFS. MTV was found to be independent risk factors for OS. In our study, SUR was the only F-18 FDG PET/CT parameter found to be significant for PFS. The development of new parameters can increase the prognostic value of F-18 FDG PET/CT.
Identifiants
pubmed: 32297136
doi: 10.1007/s12149-020-01465-8
pii: 10.1007/s12149-020-01465-8
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM